Electrokinetics has established itself as a central pillar in microfluidic research, offering a powerful, non-mechanical means to manipulate fluids and analytes. Mechanisms such as electroosmotic flow (EOF), electrophoresis (EP), and dielectrophoresis (DEP) re-main central to the field, once more layers of complexity emerge heterogeneous interfaces, viscoelastic liquids, or anisotropic droplets are introduced. Five research directions have become prominent. Field-driven manipulation of droplets and emulsions—most strikingly Janus droplets—demonstrates how asymmetric interfacial structures generate unconventional transport modes. Electrokinetic injection techniques follow as a second focus, because sharply defined sample plugs are essential for high-resolution separations and for maintaining analytical accuracy. Control of EOF is then framed as an integrated design challenge that involves tuning surface chemistry, engineering zeta potential, implementing nanoscale patterning, and navigating non-Newtonian flow behavior. Next, electrokinetic instabilities and electrically driven micromixing are examined through the lens of vortex-mediated perturbations that break diffusion limits in low-Reynolds-number flows. Finally, electrokinetic enrichment strategies—ranging from ion concentration polarization focusing to stacking-based preconcentration—demonstrate how trace analytes can be selectively accumulated to achieve detection sensitivity. Ultimately, electrokinetics is converging towards sophisticated integrated platforms and hybrid powering schemes, promising to expand microfluidic capabilities into previously inaccessible domains for analytical chemistry and diagnostics.

A microfluidic system for detecting sodium ions (Na⁺) has been developed, incorporating a micro finger-pump chip and a micro-spectrometer platform to measure Na⁺ concentration in human serum. A small volume (10 μL) of serum sample is introduced into the microchip and reacted with a preloaded reagent mixture through a two-step finger-pump actuation process. The resulting purple complex is directed into the detection area of the chip and analyzed using the micro-spectrometer at wavelengths of 555 and 666 nm. The Na⁺ concentration is then inversely derived from the measured A₅₅₅/A₆₆₆ absorbance ratio using self-written software installed on a Raspberry Pi. The entire detection process is completed in just 3 min, offering a significant advantage in meeting clinical needs compared to the traditional reporting turnaround time of several hours in medical institutions. The experimental results indicate a linear relationship between the measured absorbance ratio and Na⁺ concentration within the range of 1–200 mM, with a correlation coefficient of R² = 0.9989. Additionally, the detection results from 60 serum samples collected from chronic kidney disease (CKD) patients showed a strong agreement with those obtained using the conventional indirect ion-selective electrode (ISE) method, achieving a correlation coefficient of R² = 0.9885 and an average recovery rate of 99.4%. In summary, the proposed system provides a practical, affordable, and rapid alternative to conventional Na⁺ detection methods, making it highly promising for point-of-care (POC) testing applications.

A novel microfluidic ractopamine (RAC) detection platform consisting of a microfluidic RAC chip and a smart analysis device is proposed for the determination of RAC concentration in meat samples. This technology utilizes gold nanoparticles (AuNPs) modified with glutamic acid (GLU) and polyethyleneimine (PEI) to measure RAC concentration in food products. When RAC is present, AuNPs aggregate through hydrogen bonding, causing noticeable changes in their optical properties, which are detected using a self-built UV–visible micro-spectrophotometer. Within the range of 5 to 80 ppb, a linear relationship exists between the absorbance ratio (A_693nm/A_518nm) (Y) and RAC concentration (X), expressed as Y = 0.0054X + 0.4690, with a high coefficient of determination (R² = 0.9943). This method exhibits a detection limit of 1.0 ppb and achieves results within 3 min. The practical utility of this microfluidic assay is exemplified through the evaluation of RAC concentrations in 50 commercially available meat samples. The variance between concentrations measured using this platform and those determined via liquid chromatography–tandem mass spectrometry (LC-MS/MS) is less than 8.33%. These results underscore the viability of the microfluidic detection platform as a rapid and cost-effective solution for ensuring food safety and regulatory compliance within the livestock industry.

Chronic kidney disease (CKD) is a progressively worsening condition that erodes renal function over time, reduces quality of life, and can ultimately culminate in kidney failure with far-reaching systemic complications. In addition to reduced filtration, worsening kidney function disrupts mineral homeostasis and leads to CKD–mineral and bone disorder (CKD-MBD). Dysregulated calcium handling and maladaptive endocrine responses contribute to bone pathology and increase cardiovascular calcification risk; therefore, serial calcium monitoring remains clinically relevant for longitudinal CKD management. Conventional calcium measurements are typically obtained with centralized analyzers or laboratory assays (e.g., colorimetry and electrode/optical readouts). Despite high accuracy, the required instrumentation, controlled operating conditions, and pretreatment steps complicate rapid point-of-care deployment, especially when only microliter-scale biofluids are available. Accordingly, this study develops a finger-actuated microfluidic colorimetric platform capable of determining calcium ion concentrations in human biofluids, such as whole blood, serum, and urine. The platform integrates a three-dimensional PMMA/paper microchip with a compact reader that maintains stable temperature control while enabling CMOS-based optical detection. With just 6 μL of sample, a brief finger press propels the biofluid across an internal filtration layer, generating serum or cleaned urine that subsequently reacts with a pre-deposited murexide reagent. Under optimized conditions (1.6% reagent, 50 °C, 3 min), the signal follows a strong logarithmic relationship with calcium concentration (Y = 47.273 ln X + 28.890; R² = 0.9905), supporting quantification over 1–40 mg/dL and a detection limit of 0.2 mg/dL. Across 80 clinical CKD specimens spanning serum, whole blood, and urine, results aligned closely with the NM-BAPTA reference assay, with R² values exceeding 0.97.